Outset Medical, Inc. OM

Osisko Metals Incorporated reported second-quarter 2026 results showing a net loss of C$84.13 million, versus net income of C$0.796 million in the same period a year earlier, with basic and diluted loss per share from continuing operations of C$0.11. Over the first six months of 2026, the company’s net loss widened to C$158.82 million and loss per share from continuing operations increased to C$0.22, highlighting a sharp deterioration in profitability compared with the prior year period. We...

Outset Medical Inc (OM) reports Q2 2026 revenue of $31.6 million, up 14% sequentially, with a significant gross margin improvement and a $40 million HCA refresh agreement extending through 2028.

Outset Medical (OM) delivered earnings and revenue surprises of -26.98% and +9.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the second quarter ended June 30, 2026. Second Quarter and Recent Highlights Net revenue totaled $31.6 million, an increase of 1% compared to the prior-year period and an increase of 14% sequentially.Recurring revenue, consisting of

American Well (AMWL) delivered earnings and revenue surprises of +1.67% and +3.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026. On the same day, at 1:30 p.m. PT (4:30 p.m. ET), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will

SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company’s Inducement Plan, as a material inducement to employment with the Company, for one recently hired executive employee and two recently hire

Osisko Metals (TSX:OM) is back in focus after releasing initial 2026 drill results from its Gaspé Copper Project. The company outlined new mineralized intercepts that refine existing models and target upgrades to current resource categories. See our latest analysis for Osisko Metals. Osisko Metals’ latest Gaspé Copper drill results land against a backdrop of strong momentum, with the share price at CA$1.94 and a 1-year total shareholder return above 300% reflecting a sharp shift in investor...

Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a sharp macro-driven sector rotation following geopolitical tensions, which triggered inflation fears and rising interest rate […]

SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m. Eastern time. The live and archived webcast of the session will be available on the “Investors” section